SEC 13F Intelligence

Cornerstone Capital, Inc. / ABT

Cornerstone Capital, Inc.’s Abbott Laboratories Position

Does Cornerstone Capital, Inc. own Abbott Laboratories (ABT)? Yes — 219.5K shares worth $23M (+2.25% of its 13F portfolio) as of Q1 2026, down from 219.6K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
219.5K
% of Portfolio
+2.25%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $22MQ4 ’18Q1 ’19: $24MQ2 ’19: $25MQ3 ’19: $23MQ4 ’19: $26MQ4 ’19Q1 ’20: $23MQ2 ’20: $25MQ3 ’20: $30MQ4 ’20: $29MQ4 ’20Q1 ’21: $31MQ2 ’21: $31MQ3 ’21: $31MQ4 ’21: $37MQ4 ’21Q1 ’22: $31MQ2 ’22: $28MQ3 ’22: $25MQ4 ’22: $28MQ4 ’22Q1 ’23: $27MQ2 ’23: $28MQ3 ’23: $24MQ4 ’23: $27MQ4 ’23Q1 ’24: $27MQ2 ’24: $25MQ3 ’24: $29MQ4 ’24: $26MQ4 ’24Q1 ’25: $30MQ2 ’25: $29MQ3 ’25: $29MQ4 ’25: $28MQ4 ’25Q1 ’26: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026219.5K$23M+2.25%
Q4 2025219.6K$28M+2.71%
Q3 2025219.4K$29M+2.88%
Q2 2025215.4K$29M+3.06%
Q1 2025227.3K$30M+3.25%
Q4 2024229.4K$26M+2.73%
Q3 2024250.9K$29M+2.67%
Q2 2024240.2K$25M+2.52%
Q1 2024241.8K$27M+2.82%
Q4 2023241.6K$27M+2.91%
Q3 2023252.8K$24M+2.95%
Q2 2023255.2K$28M+3.22%
Q1 2023263.8K$27M+3.22%
Q4 2022259.0K$28M+3.64%
Q3 2022259.6K$25M+3.53%
Q2 2022254.2K$28M+3.54%
Q1 2022259.0K$31M+3.44%
Q4 2021262.5K$37M+3.94%
Q3 2021262.8K$31M+3.58%
Q2 2021267.5K$31M+3.52%
Q1 2021261.1K$31M+3.79%
Q4 2020267.1K$29M+3.76%
Q3 2020277.1K$30M+4.35%
Q2 2020277.8K$25M+4.33%
Q1 2020287.4K$23M+4.71%
Q4 2019293.7K$26M+3.60%
Q3 2019278.6K$23M+3.63%
Q2 2019299.8K$25M+3.95%
Q1 2019298.3K$24M+3.94%
Q4 2018308.9K$22M+3.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cornerstone Capital, Inc.’s full portfolio or all institutional holders of ABT.